🇵🇪 Country Profile

Peru

Fast-growing pharmaceutical trade with Peru

🇵🇪 $110M
All data from DGCIS India export records (fiscal year, April–March).
$110M
Scale
Peru's patients receive $110M in Indian pharmaceutical products annually, almost entirely finished medicines ready for dispensing.
78%
Medicine
Overwhelmingly finished medicines, drug formulations account for 78% of shipments.
3.1×
Trajectory
One of the faster-growing relationships, India's pharmaceutical supply to Peru has expanded 3.1× over the decade.
Context
Part of India's pharmaceutical supply network across Americas.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Peru, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicines $85.4M (78.0%) Medicine Ingredients $9.4M (8.6%) Vaccines $8.2M (7.5%) Surgical & Hospital Supplies $6.2M (5.6%) Traditional & Herbal $0.37M (0.3%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in Peru Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Peru: $15.9M across 36 filings (2013-2021).